NOT-CA-20-085: Pre-Application Webinar for RFA-CA-20-042, 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)

Pre-Application Webinar for RFA-CA-20-042, 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)

Notice Number:

NOT-CA-20-085

Key Dates

Release Date:

July 14, 2020

Related Announcements

RFA-CA-20-042 - 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The NCI will hold a pre-application webinar on Friday, August 21, 2020, from 2:00 - 3:00 PM (EDT) for the Funding Opportunity Announcement (FOA) RFA-CA-20-042 entitled "3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)”.

NCI staff members involved in the FOA will provide a brief overview of the above-referenced FOA for potential applicants by explaining the goals and objectives for the FOA, as well as answering questions from webinar attendees. Please submit questions by August 19, 2020 to Philipp.Oberdoerffer@nih.gov. Attendees will also be able to submit questions during the webinar. Questions submitted early will be answered first.

To join the webinar, pre-registration is required through Webex: https://cbiit.webex.com/cbiit/j.php?RGID=rc71f89b5dcb07b10e0162b2c47f53b35. Specific webinar information will be provided upon registration.

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-20-042. A document highlighting frequently asked questions and corresponding answers will be posted to the HTAN website following the webinar.

Inquiries

Please direct all inquiries to:

Philipp Oberdoerffer, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-760-6681
Email:Philipp.Oberdoerffer@nih.gov